Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Adenocarcinoma. Found 91 abstracts

no pagination
Judd J, Borghaei H. Combining Immunotherapy and Chemotherapy for Non-Small Cell Lung Cancer. Thorac Surg Clin. 2020 May;30(2):199-206.
Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algul H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. The New England journal of medicine. 2019 Jul 25;381(4):317-27.   PMCID: PMC6810605
Roach M, Moughan J, Lawton CA, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR, Shipley WU, Sandler HM. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. Lancet Oncol. 2018 Nov;19(11):1504-15.   PMCID: PMC6540797
Boland PM, Meyer JE, Berger AC, Cohen SJ, Neuman T, Cooper HS, Olszanski AJ, Davey M, Cheng JD, Lebenthal A, Burtness BA, Scott WJ, Astsaturov IA. Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection. Am J Clin Oncol. 2017 Aug;40(4):393-8.   PMCID: PMC5026539
Fortner RT, Schock H, Jung S, Allen NE, Arslan AA, Brinton LA, Egleston BL, Falk RT, Gunter MJ, Helzlsouer KJ, Idahl A, Johnson TS, Kaaks R, Krogh V, Lundin E, Merritt MA, Navarro C, Onland-Moret NC, Palli D, Shu XO, Sluss PM, Staats PN, Trichopoulou A, Weiderpass E, Zeleniuch-Jacquotte A, Zheng W, Dorgan JF. Anti-Mullerian hormone and endometrial cancer: a multi-cohort study. Br J Cancer. 2017 Oct 24;117(9):1412-8.   PMCID: PMC5672934
Hellmann MD, Rizvi NA, Goldman JW, Gettinger SN, Borghaei H, Brahmer JR, Ready NE, Gerber DE, Chow LQ, Juergens RA, Shepherd FA, Laurie SA, Geese WJ, Agrawal S, Young TC, Li X, Antonia SJ. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. Lancet Oncol. 2017 Jan;18(1):31-41.   PMCID: PMC5476941
Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, Badiozamani KR, Lawton CA, Horwitz EM, Michalski JM, Roof K, Beyer DC, Zhang Q, Sandler HM. Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621. Cancer. 2017 Jul;123(13):2489-96.   PMCID: PMC5474197
Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G, Nickols NG, Aronson WJ, Sadeghi A, Kamrava M, Demanes DJ, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol. 2017 May;71(5):766-73.
Lawton CA, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M, Kwok Y, Dignam JJ, Sandler HM. Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Jun;98(2):296-303.   PMCID: PMC5603177
Mirhadi AJ, Zhang Q, Hanks GE, Lepor H, Grignon DJ, Peters CA, Rosenthal SA, Zeitzer K, Radwan JS, Lawton C, Parliament MB, Reznik RS, Sandler HM. Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Mar;97(3):511-5.   PMCID: PMC5485922
Narsinh KH, Van Buskirk M, Kennedy AS, Suhail M, Alsaikhan N, Hoh CK, Thurston K, Minocha J, Ball DS, Cohen SJ, Cohn M, Coldwell DM, Drooz A, Ehrenwald E, Kanani S, Nutting CW, Moeslein FM, Savin MA, Schirm S, Putnam SG, Sharma NK, Wang EA, Rose SC. Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with 90Y Radioembolization. Radiology. 2017 Jan;282(1):281-8.   PMCID: PMC5207118
Rice TW, Ishwaran H, Hofstetter WL, Schipper PH, Kesler KA, Law S, Lerut EM, Denlinger CE, Salo JA, Scott WJ, Watson TJ, Allen MS, Chen LQ, Rusch VW, Cerfolio RJ, Luketich JD, Duranceau A, Darling GE, Pera M, Apperson-Hansen C, Blackstone EH. Esophageal Cancer: Associations With (pN+) Lymph Node Metastases. Ann Surg. 2017 Jan;265(1):122-9.   PMCID: PMC5405457
Burtness B, Powell M, Catalano P, Berlin J, Liles DK, Chapman AE, Mitchell E, Benson AB. Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study. Am J Clin Oncol. 2016 Aug;39(4):340-5.   PMCID: PMC4177955
Hoffman JP, Reddy SS. Is It Time for Total Neoadjuvant Therapy for Patients With Resectable Pancreatic Adenocarcinoma?. J Oncol Pract. 2016 Sep;12(9):780-1.   PMCID: Letter
Li D, Moughan J, Crane C, Hoffman JP, Regine WF, Abrams RA, Safran H, Liu C, Chang P, Freedman GM, Winter KA, Guha C, Abbruzzese JL. RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704. Int J Radiat Oncol Biol Phys. 2016 Mar;94(3):554-60.   PMCID: PMC4876948
Thunnissen E, Blaauwgeers HJ, de Cuba EM, Yick CY, Flieder DB. Ex Vivo Artifacts and Histopathologic Pitfalls in the Lung. Archives of pathology & laboratory medicine. 2016 Mar;140(3):212-20.
Chen KT, Devarajan K, Hoffman JP. Morbidity among long-term survivors after pancreatoduodenectomy for pancreatic adenocarcinoma. Ann Surg Oncol. 2015 Apr;22(4):1185-9.
Marks EI, Brennan M, El-Deiry WS. Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma. Cancer Biology & Therapy. 2015 Aug;16(8):1136-9.   PMCID: 4622690
Moayyedi P, Weinberg DS, Schunemann H, Chak A. Management of pancreatic cysts in an evidence-based world [Comment]. Gastroenterology. 2015 Apr;148(4):692-5.   PMCID: Comment
Porpiglia AS, Sigurdson ER. Surgical Options in the Treatment of Lower Gastrointestinal Tract Cancers. Current treatment options in oncology. 2015 Sep;16(9):46.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Adenocarcinoma

Adenocarcinoma pathology Male Middle Aged Aged therapeutic use Adult Female mortality Neoplasm Staging therapy methods blood adverse effects Pancreatic Neoplasms Survival Rate administration & dosage Disease-Free Survival Prostatic Neoplasms surgery 80 and over Aged Neoplasm Grading Prognosis Antineoplastic Combined Chemotherapy Protocols Androgen Antagonists drug therapy Follow-Up Studies Treatment Outcome Prostate-Specific Antigen Multivariate Analysis Retrospective Studies Kaplan-Meier Estimate Combined Modality Therapy Fluorouracil secondary Squamous Cell Carcinoma Time Factors radiotherapy complications Lung Neoplasms Neoplasm Metastasis metabolism blood supply diagnosis Proportional Hazards Models Flutamide Taxoids Prostatectomy Prospective Studies Tumor Biomarkers Drug Administration Schedule Goserelin Kallikreins CA-19-9 Antigen Progression-Free Survival prevention & control Antineoplastic Agents Conformal Radiotherapy analogs & derivatives Chemoradiotherapy Lung Rectal Neoplasms Esophagectomy genetics United States Local Neoplasm Recurrence Esophageal Neoplasms Non-Small-Cell Lung Carcinoma Machine Learning Piperazines Canada Therapeutic Embolization Magnetic Resonance Imaging Piperidines Anilides postprostatectomy Gleason 9 Survivors Yttrium Radioisotopes Datasets as Topic chemotherapy Squamous cell carcinoma Paclitaxel Intensity-Modulated Radiotherapy Liver Enoxaparin etiology Colonic Neoplasms metastatic colorectal adenocarcinoma Radiotherapy Double-Blind Method Novartis Zeneca-Genmab-Regeneron-BioNTech-Cantargia AB-Amgen-AbbVie Genetic Polymorphism Phthalazines statistics & numerical data Lymph Nodes Quinazolines Smooth Muscle Checkpoint inhibition PharmaMar Axiom-Takeda-Huya Bio Thromboembolism Arteriovenous Fistula Case-Control Studies Consultant for BMS Lung Diseases Gastrointestinal Endoscopy BRCA2 Genes androgen deprivation Carcinoembryonic Antigen Gonadotropin-Releasing Hormone Postoperative Complications Specimen Handling BRCA1 Genes Biomarkers docetaxel Carboplatin Adjuvant Chemotherapy Morbidity chemically induced Angiography Treatment Failure tumor marker Non-small cell lung cancer Germ-Line Mutation Diagnostic Errors Pancreatic Cyst Cetuximab Lilly Gleason 10 Biopsy Asymptomatic Diseases Molecular Targeted Therapy Immunotherapy and BMS Celgene RecQ Helicases Neoplasm Invasiveness Anti-Mullerian Hormone Pancreaticoduodenectomy Lymphatic Metastasis radiation Radiation Dose Fractionation Genentech Lilly-Celgene-Pfizer-Merck-EMD-Serono-Boehringer Ingelheim-Astra Asthma Deoxycytidine Endometrial Neoplasms Pancreatic Ductal Carcinoma Lymph Node Excision Adjuvant Radiotherapy Chemo-immunotherapy Response Evaluation Criteria in Solid Tumors
Last updated on Sunday, July 05, 2020